Medicare Enrolled
Dr. Krishan Kalra, MD
Cardiovascular Disease · Trenton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kalra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalra
Dr. Krishan Kalra is a cardiovascular disease specialist in Trenton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalra performed 3,741 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kalra received a total of $2,695 from 25 pharmaceutical and/or device companies across 168 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in NJ
$2,695 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,741
Medicare services
Top 31% in NJ for cardiovascular disease
Not available
Unique patients (not deduplicated)
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
951 | $53 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
515 | $66 | $575 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
426 | $11 | $411 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
371 | $40 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
252 | $65 | $704 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
158 | $108 | $5,120 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
152 | $44 | $1,124 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
145 | $19 | $178 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
118 | $23 | $216 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
118 | $98 | $575 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
78 | $108 | $818 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
68 | $276 | $580 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
58 | $21 | $390 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
47 | $53 | $468 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
47 | $182 | $329 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
35 | $33 | $500 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
31 | $44 | $206 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
28 | $109 | $212 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
27 | $29 | $156 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $98 | $744 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
22 | $17 | $144 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $12 | $94 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $70 | $348 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
14 | $14 | $216 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
13 | $14 | $136 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.8% high complexity
9.6% medium
77.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,695
Total received (2018-2024)
Avg $385/year across 7 years
Bottom 47% in NJ for cardiovascular disease
25
Companies
168
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$432
2023
$360
2022
$438
2021
$392
2020
$213
2019
$490
2018
$370
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$114
BIOTRONIK INC.
$79
Kiniksa Pharmaceuticals International, plc
$67
Merck Sharp & Dohme LLC
$50
Abbott Laboratories
$43
Amgen Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 60.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$482
Amgen Inc.
$239
Janssen Pharmaceuticals, Inc
$218
Merck Sharp & Dohme LLC
$211
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$207
Abbott Laboratories
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
PFIZER INC.
$124
AstraZeneca Pharmaceuticals LP
$92
E.R. Squibb & Sons, L.L.C.
$86
Kiniksa Pharmaceuticals, Ltd.
$82
Kowa Pharmaceuticals America, Inc.
$82
BIOTRONIK INC.
$79
Merck Sharp & Dohme Corporation
$77
Preventice Services, LLC
$70
Kiniksa Pharmaceuticals International, plc
$67
Amarin Pharma Inc.
$59
ARBOR PHARMACEUTICALS, INC.
$48
Daiichi Sankyo Inc.
$42
SANOFI-AVENTIS U.S. LLC
$33
W. L. Gore & Associates, Inc.
$23
Boston Scientific Corporation
$19
BOSTON SCIENTIFIC CORPORATION
$19
GENZYME CORPORATION
$16
Medtronic Vascular, Inc.
$12
Top 3 companies account for 34.9% of all-time payments
Associated products mentioned in payments ›
AMVIA EDGE · Arcalyst · Assurity Pacemaker · BG Mini Plus · BRILINTA · Bidil · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edarbyclor · FABRAZYME · FARXIGA · INJECTAFER · JARDIANCE · JOT DX · LEQVIO · LifeVest · Livalo · MITRACLIP · PRADAXA · PRALUENT · Pacemakers · Repatha · Reveal LINQ · Unify Assura CRT Defibrillator · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
300
County median income
$96,333
Nearest hospital to ZIP centroid (approximate)
CAPITAL HEALTH REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kalra is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kalra experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Kalra performed 951 chronic care management, first 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kalra receive payments from pharmaceutical companies?
Yes. Dr. Kalra received a total of $2,695 from 25 companies across 168 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalra's costs compare to other cardiologists in Trenton?
Dr. Kalra's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Trenton
Browse cardiologists in Trenton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology